Victor Kande Betu Ku Mesu

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial

Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau et al. · The Lancet · 2017 · 265 citations

Parasitic Protozoa, African Trypanosomiasis, Pathogenesis +6

Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003

Pascal Lutumba, Jo Robays, Constantin Miaka Mia Bilenge et al. · Emerging infectious diseases · 2005 · 63 citations · Full text

Human African Trypanosomiasis, Epidemiological Outcome, African Trypanosomiasis +15

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study

Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau et al. · The Lancet Global Health · 2021 · 55 citations · Full text

Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk

Crispin Lumbala, Pere P. Simarro, Giuliano Cecchi et al. · International Journal of Health Geographics · 2015 · 51 citations · Full text

Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo

Jo Robays, P Lefèvre, Pascal Lutumba et al. · Tropical Medicine & International Health · 2007 · 46 citations · Full text